[HTML][HTML] Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comprehensive review
Abstract Cardiovascular Magnetic Resonance is increasingly used to differentiate the
aetiology of cardiomyopathies. Late Gadolinium Enhancement (LGE) is the reference …
aetiology of cardiomyopathies. Late Gadolinium Enhancement (LGE) is the reference …
[HTML][HTML] Normal values for cardiovascular magnetic resonance in adults and children
N Kawel-Boehm, A Maceira… - Journal of …, 2015 - Elsevier
Morphological and functional parameters such as chamber size and function, aortic
diameters and distensibility, flow and T1 and T2* relaxation time can be assessed and …
diameters and distensibility, flow and T1 and T2* relaxation time can be assessed and …
Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis
L Zhang, M Awadalla, SS Mahmood… - European heart …, 2020 - academic.oup.com
Aims Myocarditis is a potentially fatal complication of immune checkpoint inhibitors (ICI).
Sparse data exist on the use of cardiovascular magnetic resonance (CMR) in ICI-associated …
Sparse data exist on the use of cardiovascular magnetic resonance (CMR) in ICI-associated …
[HTML][HTML] Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the …
Rapid innovations in cardiovascular magnetic resonance (CMR) now permit the routine
acquisition of quantitative measures of myocardial and blood T1 which are key tissue …
acquisition of quantitative measures of myocardial and blood T1 which are key tissue …
Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy
P Garcia‐Pavia, F Bengel, D Brito… - European journal of …, 2021 - Wiley Online Library
Transthyretin amyloid cardiomyopathy (ATTR‐CM) is a life‐threatening condition with a
heterogeneous clinical presentation. The recent availability of treatment for ATTR‐CM has …
heterogeneous clinical presentation. The recent availability of treatment for ATTR‐CM has …
T1 mapping and survival in systemic light-chain amyloidosis
SM Banypersad, M Fontana, V Maestrini… - European heart …, 2015 - academic.oup.com
Aims To assess the prognostic value of myocardial pre-contrast T1 and extracellular volume
(ECV) in systemic amyloid light-chain (AL) amyloidosis using cardiovascular magnetic …
(ECV) in systemic amyloid light-chain (AL) amyloidosis using cardiovascular magnetic …
Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping
DM Sado, SK White, SK Piechnik… - Circulation …, 2013 - Am Heart Assoc
Background—Anderson-Fabry disease (AFD) is a rare but underdiagnosed intracellular lipid
disorder that can cause left ventricular hypertrophy (LVH). Lipid is known to shorten the …
disorder that can cause left ventricular hypertrophy (LVH). Lipid is known to shorten the …
[HTML][HTML] Myocardial T1 and T2 mapping: techniques and clinical applications
Cardiac magnetic resonance (CMR) imaging is widely used in various medical fields related
to cardiovascular diseases. Rapid technological innovations in magnetic resonance imaging …
to cardiovascular diseases. Rapid technological innovations in magnetic resonance imaging …
Human non-contrast T1 values and correlation with histology in diffuse fibrosis
Background Aortic stenosis (AS) leads to diffuse fibrosis in the myocardium, which is linked
to adverse outcome. Myocardial T1 values change with tissue composition. Objective To test …
to adverse outcome. Myocardial T1 values change with tissue composition. Objective To test …
Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume
Background—Extracellular matrix expansion is a key element of ventricular remodeling and
a potential therapeutic target. Cardiovascular magnetic resonance (CMR) T1-mapping …
a potential therapeutic target. Cardiovascular magnetic resonance (CMR) T1-mapping …